Gallium Ga 68 gozetotide Side Effects
Applies to gallium Ga 68 gozetotide: intravenous powder for injection.
Gastrointestinal
Uncommon (0.1% to 1%): Constipation, nausea, vomiting, diarrhea, dry mouth[Ref]
General
The most commonly reported adverse reactions were fatigue, nausea, diarrhea, dizziness, constipation, and vomiting.[Ref]
Local
Uncommon (0.1% to 1%): Injection site reactions (includes injection site warmth and hematoma), chills[Ref]
Other
Common (1% to 10%): Fatigue[Ref]
More about gallium Ga 68 gozetotide
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: radiologic conjugating agents
Professional resources
Other brands
Related treatment guides
References
1. Product Information. Locametz (gozetotide). Advanced Accelerator Applications. 2022.
2. Product Information. Locametz (gozetotide). Advanced Accelerator Applications (UK & Ireland) Ltd. 2023.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.
